ImmunityBio(IBRX)
$6.07-0.60 (-9.00%)
IBRX
ImmunityBio earnings date
$6.07
At close:-0.60 (-9.00%)
Want to see IBRX full AI Analyst Report?
ImmunityBio (IBRX) Q2 2022 Earnings Report
2,637 Followers
IBRX Q2 2022 EPS Results
- Actual EPS
- -$0.24
- Consensus EPS
- -$0.24
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -$0.23
IBRX Q2 2022 Revenue Results
- Actual Revenue
- $35.00K
- Expected Revenue
- $25.00K
- Beat/Miss
- Beat by +$10.00K
- YoY Revenue Growth
- -89.68%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/08/2022
- Time
- TBA
- Conference Call
- Monday, August 8, 2022
IBRX Upcoming Earnings
ImmunityBio's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
IBRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.14- | -0.06 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.07-0.18 | -0.07 | -157.14% (-0.11) | |
| Aug 04, 2026 | 2026 (Q2) | -0.08-0.22 | -0.1 | -120.00% (-0.12) | |
| May 07, 2026 | 2026 (Q1) | -0.07-0.62 | -0.15 | -313.33% (-0.47) | |
| Mar 03, 2026 | 2025 (Q4) | -0.08-0.06 | -0.09 | 33.33% (+0.03) | |
| Nov 04, 2025 | 2025 (Q3) | -0.11-0.07 | -0.14 | 50.00% (+0.07) | |
| Aug 05, 2025 | 2025 (Q2) | -0.11-0.10 | -0.2 | 50.00% (+0.10) | |
| May 12, 2025 | 2025 (Q1) | -0.13-0.15 | -0.2 | 25.00% (+0.05) | |
| Mar 03, 2025 | 2024 (Q4) | -0.20-0.09 | -0.36 | 75.00% (+0.27) | |
| Nov 12, 2024 | 2024 (Q3) | -0.18-0.14 | -0.19 | 26.32% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
